Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia. Lan MJ, R Ogden T, Kumar D, Stern Y, Parsey RV, Pelton GH, Rubin-Falcone H, Pradhaban G, Zanderigo F, Miller JM, et al. J Alzheimers Dis. 2017; 60(3):939-947. PMID: 28984586. Abstract Comment Bookmark Recommend Follow Comment | Bookmark | Recommend | Follow